Anhidrosis
Showing 1 - 19 of 19
DF-003 in ex Vivo Assays Using Peripheral Blood Mononuclear Cell
Recruiting
- Unrecognized Condition
- Adult subjects with ROSAH syndrome
-
Lyon, Rhône-Alpes, FranceHôpital Nord Croix Rousse
Sep 9, 2022
N/A, as no Specific Medical Condition Will be Treated Trial in Hamburg (IncobotulinumtoxinA)
Active, not recruiting
- N/A, as no Specific Medical Condition Will be Treated
-
Hamburg, GermanyMerz Investigational Site #0490385
Jan 31, 2023
Disorders: Genetics and Disease Characteristics
Recruiting
- Familial Mediterranean Fever (FMF)
- +6 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 21, 2023
Healthy Trial in Porto (Placebo technique, Suboccipital inhibition technique, Frontal lift technique)
Not yet recruiting
- Healthy
- Placebo technique
- +4 more
-
Porto, PortugalEscola Superior da Saúde do Porto
Jun 16, 2023
Biomarker for Patients With Fabry Disease (BioFabry)
Active, not recruiting
- Angiokeratomas
- +3 more
-
Rostock, Germany
- +2 more
May 12, 2021
Horner's Syndrome Developing After Interscalene Brachial Plexus
Completed
- Brachial Plexus Block
- +2 more
- Interscalene brachial plexus block
- 0.75% ropivacaine
-
Daegu, Korea, Republic ofDaegu Catholic University Medical Center
Jun 15, 2021
Atrial Fibrillation New Onset Trial (Stellate ganglion block, Bupivacain, Saline)
Not yet recruiting
- Atrial Fibrillation New Onset
- Stellate ganglion block
- +2 more
- (no location specified)
Dec 9, 2022
Diabete Type 2, Diabetic Foot, Neuropathy, Diabetic Trial (LSCI)
Not yet recruiting
- Diabete Type 2
- +4 more
- LSCI
- (no location specified)
May 2, 2023
Post Acute COVID-19 Syndrome, Long COVID, Long Covid19 Trial in New York (stellate ganglion block with 0.5% bupivacaine)
Recruiting
- Post Acute COVID-19 Syndrome
- +14 more
- stellate ganglion block with 0.5% bupivacaine
-
New York, New YorkHudson Medical
Jan 10, 2023
HSAN Type IV Trial (Droxidopa (L-DOPS), Placebo)
Withdrawn
- HSAN Type IV
- Droxidopa (L-DOPS)
- Placebo
- (no location specified)
Sep 9, 2016
Partial-onset Seizures Trial in Worldwide (Perampanel, Placebo)
Natural History in Fabry Patients With IVS4+919G>A Mutation
Unknown status
- Fabry Disease, Cardiac Variant
- Family pedigree and data collection
- (no location specified)
Jul 16, 2017
Transient Receptor Potential Vanilloid One Receptor Expression
Completed
- Epigastric Pain
- +3 more
-
Milwaukee, WisconsinMedical College of Wisconsin
Oct 21, 2015
Horner's Syndrome Trial in Daegu (Supraclavicular block, Interscalene block)
Completed
- Horner's Syndrome
- Supraclavicular block
- Interscalene block
-
Daegu, Korea, Republic ofDaegu Catholic University Medical Center
Apr 6, 2014
Predictive Factors for Hypotensive Bradycardic Events During
Completed
- Syncope, Vasovagal
- Interscalene brachial plexus block
-
Daegu, Korea, Republic ofDaegu Catholic University Medical Center
Oct 7, 2013
Fabry Disease Trial in Worldwide (Fabrazyme (agalsidase beta), Placebo)
Completed
- Fabry Disease
- Fabrazyme (agalsidase beta)
- Placebo
-
Birmingham, Alabama
- +25 more
Dec 2, 2013
